Postprocedural trans‐mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge‐to‐edge repair
- 26 May 2023
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 102 (2) , 310-317
Abstract
Background: The relationship between high postprocedural mean gradient (ppMG) and clinical events following mitral valve transcatheter edge‐to‐edge repair (MV‐TEER) in patients with degenerative mitral regurgitation (DMR) is still debated.Aim: The purpose of this study was to evaluate the effect of elevated ppMG after MV‐TEER on clinical events in patients with DMR at 1‐year follow‐up.Methods: The study included 371 patients with DMR treated with MV‐TEER enrolled in the “Multi‐center Italian Society of Interventional Cardiology (GISE) registry of trans‐catheter treatment of mitral valve regurgitation” (GIOTTO) registry. Patients were stratified in tertiles according to ppMG. Primary endpoint was a composite of all‐cause death and hospitalization due to heart failure at 1‐year follow‐up.Results: Patients were stratified as follows: 187 with a ppMG ≤ 3 mmHg, 77 with a ppMG > 3/=4 mmHg, and 107 with a ppMG > 4 mmHg. Clinical follow‐up was available in all subjects. At multivariate analysis, neither a ppMG > 4 mmHg nor a ppMG ≥ 5 mmHg were independently associated with the outcome. Notably, the risk of elevated residual MR (rMR > 2+) was significantly higher in patients belonging to the highest tertile of ppMG (p = 0.009). The association of ppMG > 4 mmHg and rMR ≥ 2+ was strongly and independently associated with adverse events (hazard ratio: 1.98; 95% confidence interval: [1.10–3.58]).Conclusions: In a real‐world cohort of patients suffering DMR and treated with MV‐TEER, isolated ppMG was not associated with the outcome at 1‐year follow‐up. A high proportion of patients showed both elevated ppMG and rMR and their combination appeared to be a strong predictor of adverse events.Keywords
This publication has 21 references indexed in Scilit:
- Elevated Mitral Valve Pressure Gradient Is Predictive of Long‐Term Outcome After Percutaneous Edge‐to‐Edge Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation (MR), But Not in Functional MRJournal of the American Heart Association, 2019
- Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart FailureJACC: Cardiovascular Interventions, 2017
- Recommendations for Noninvasive Evaluation of Native Valvular RegurgitationJournal of the American Society of Echocardiography, 2017
- Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral RegurgitationNew England Journal of Medicine, 2016
- What is a “good” result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitationThe Journal of Thoracic and Cardiovascular Surgery, 2016
- Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint DefinitionsJACC, 2015
- Secondary Mitral Regurgitation in Heart FailureJACC, 2015
- Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitationThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Percutaneous Repair or Surgery for Mitral RegurgitationNew England Journal of Medicine, 2011
- Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practiceEuropean Heart Journal - Cardiovascular Imaging, 2009